SEC Form 4 research
| Issuer | Nemus Bioscience, Inc. |
|---|---|
| Tickers | NMUS, EMBI, SKYE, LGLRD, LGLR |
| Reporting owners | 45 |
| Officers and directors | 6 |
| Last public filing | 2026-09-24 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-09-24 | 2026-09-23 | Schwab Andrew J. | S | 4,528 | $1.61 | Not reported |
| 2026-09-24 | 2026-09-23 | Schwab Andrew J. | S | 114,851 | $1.61 | Not reported |
| 2026-09-24 | 2026-09-22 | Schwab Andrew J. | S | 1,088 | $1.65 | Not reported |
| 2026-09-24 | 2026-09-22 | Schwab Andrew J. | S | 27,612 | $1.65 | Not reported |
| 2026-09-24 | 2026-09-23 | 5AM CO-INVESTORS II LP, 5AM Partners II, LLC, 5AM Partners VII, LLC, 5AM Ventures II LP, 5AM Ventures VII, L.P., DIEKMAN JOHN D, PARMAR KUSH, ROCKLAGE SCOTT M | S | 4,528 | $1.61 | Not reported |
| 2026-09-24 | 2026-09-23 | 5AM CO-INVESTORS II LP, 5AM Partners II, LLC, 5AM Partners VII, LLC, 5AM Ventures II LP, 5AM Ventures VII, L.P., DIEKMAN JOHN D, PARMAR KUSH, ROCKLAGE SCOTT M | S | 114,851 | $1.61 | Not reported |
| 2026-09-24 | 2026-09-22 | 5AM CO-INVESTORS II LP, 5AM Partners II, LLC, 5AM Partners VII, LLC, 5AM Ventures II LP, 5AM Ventures VII, L.P., DIEKMAN JOHN D, PARMAR KUSH, ROCKLAGE SCOTT M | S | 1,088 | $1.65 | Not reported |
| 2026-09-24 | 2026-09-22 | 5AM CO-INVESTORS II LP, 5AM Partners II, LLC, 5AM Partners VII, LLC, 5AM Ventures II LP, 5AM Ventures VII, L.P., DIEKMAN JOHN D, PARMAR KUSH, ROCKLAGE SCOTT M | S | 27,612 | $1.65 | Not reported |
| 2026-09-18 | 2026-09-16 | Schwab Andrew J. | S | 1,285 | $1.91 | Not reported |
| 2026-09-18 | 2026-09-16 | Schwab Andrew J. | S | 32,607 | $1.91 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.